SC
MRK icon

Savant Capital’s Merck MRK Stock Holding History

Savant Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,886
Closed -$139K – 504
2021
Q1 		$139K Buy
+1,886
New +$139K 0.01% 458

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Savant Capital's MRK Position: Q1 2026 in Review

Savant Capital increased its Merck (MRK) stake by 21% in Q1 2026, buying an estimated $2.15M and bringing the position to 106,935 shares worth $12.9M. The position accounts for 0.06% of the portfolio, ranked #162.

Savant Capital first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.8M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Savant Capital held 106,935 shares of Merck worth $12.9M as of Q1 2026.
  • Savant Capital bought 18,663 Merck shares in Q1 2026, an estimated $2.15M.
  • Merck made up 0.06% of Savant Capital's portfolio in Q1 2026, its #162 holding.
  • Savant Capital first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Savant Capital's Merck position peaked at $15.8M in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Savant Capital's 13F filing for Q1 2026, filed 4 May 2026.